What are the treatment options for human leukocyte antigen (HLA) B27–associated reactive arthritis?

Updated: Oct 30, 2018
  • Author: Anna Luisa Di Lorenzo, MBBCh; Chief Editor: Andrew A Dahl, MD, FACS  more...
  • Print


Treatment is empirical and aimed at relieving symptoms. Patient education, reassurance, and physical therapy are of paramount importance. Acute arthritis is treated with analgesics and nonsteroidal anti-inflammatory drugs, such as indomethacin. Whether antibiotics help in reactive arthritis is unclear. However, it is known that treatment of acute chlamydial urethritis may prevent subsequent reactive arthritis.

Systemic corticosteroids should be avoided because they can aggravate the cutaneous manifestations of the disease, but local administration can help persistent monoarthritis, fasciitis, and tendonitis. In chronic destructive arthritis, cytotoxic drugs, such as methotrexate or azathioprine, may be beneficial. Uveitis usually is treated with topical periocular or systemic corticosteroids depending on the severity of the condition. The molecular mechanisms of HLA-B27-associated arthritis and uveitis are becoming better understood and may someday soon contribute to specific targeted immunotherapy. [17]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!